Ultrasonographic Effects of Fascia Correction Kinesiotaping

Investigation of the Physiological Effects of Fascia Correction Kinesiotaping in Healthy Adults: An Ultrasonographic Study

Single-center, within-subject repeated-measures study The aim of the present study was to investigate the acute effects of kinesiotaping applied using the fascia correction technique with different tension levels on fascial layers and associated musculature in healthy individuals.

Outcome measurements. The primary outcome was the ultrasonographically measured thickness of the fascial layers, while secondary outcomes included the thickness of the superficial and deep flexor muscle layers and the subcutaneous tissue.

Study Overview

• Status: Completed
• Conditions: Healthy
• Intervention / Treatment: Other: Kinesiotaping

Detailed Description

The fascial system plays an important role in force transmission, movement coordination, and interaction between musculoskeletal structures. Kinesiotaping is a commonly used therapeutic approach in rehabilitation, and the fascia correction technique has been proposed to influence fascial mobility and mechanical properties. However, the acute effects of different kinesiotape tension levels applied with the fascia correction technique on fascial and underlying musculoskeletal structures remain unclear.This single-center, within-subject repeated-measures study aims to investigate the immediate effects of kinesiotaping applied using the fascia correction technique with different tension levels on fascial layers and associated soft tissues in healthy individuals.

Healthy volunteers aged 18 years or older will be included. Participants will undergo kinesiotape application with different tension levels according to the study protocol. Ultrasonographic assessments will be performed to evaluate changes in fascial layer thickness as the primary outcome. Secondary outcomes will include ultrasonographic measurements of superficial and deep flexor muscle thickness and subcutaneous tissue thickness.

The study is designed to provide objective ultrasonographic measurements of acute tissue responses following kinesiotaping application and to improve understanding of the potential mechanical effects of the fascia correction technique on fascial and musculoskeletal structures.

• Study Type: Interventional
• Enrollment (Actual): 80
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey (Türkiye)
  • Istanbul, Turkey (Türkiye)
    • Haydarpaşa Numune Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

A total of 80 healthy volunteers aged 18 years or older were included in the study. Participants had no current or previous serious musculoskeletal injury, pain, or neurological disorder affecting the upper extremity within the past six months

Exclusion Criteria:

Individuals were excluded if they were pregnant; regularly participated in high-level athletic training or competitive sports, had a history of skin allergy to adhesive materials; or had previous kinesiotaping application within the last month.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Healthy Volunteers; Participants received kinesiotaping using the fascia correction technique at different tension levels according to the study protocol. Each participant underwent all intervention conditions, and ultrasonographic measurements were performed before and after each application.	Other: Kinesiotaping; Fascia correction technique kinesiotaping

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The superficial antebrachial fascia thickness	ultrasonographic measurements were obtained from the dominant forearm at the mid-forearm level. the hyperechoic linear structure separating the subcutaneous tissue from the superficial flexor muscles was defined as superficial antebrachial fascia thickness	Baseline and 30 minutes after two different interventions (different tensions). A one-week washout period was implemented between applications
The deep antebrachial fascia thickness	Ultrasonographic measurements were obtained from the dominant forearm at the mid-forearm level. the hyperechoic linear structure separating the superficial and deep flxor muscles was defined as superficial antebrachial fascia thickness	Baseline and 30 minutes after two different interventions (different tensions). A one-week washout period was implemented between applications

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
the subcutaneous tissue thickness	Subcutaneous tissue thickness measured by B-mode ultrasonography (millimeters)	Baseline and 30 minutes after two different interventions (different tensions). A one-week washout period was implemented between applications
Forearm Superficial Flexor Muscle Thickness	Forearm superficial flexor muscle thickness measured by B-mode ultrasonography (millimeters)	Baseline and 30 minutes after two different interventions (different tensions). A one-week washout period was implemented between applications
Forearm deep flexor muscle thickness measured by B-mode ultrasonography (millimeters)	Forearm deep flexor muscle thickness measured by B-mode ultrasonography (millimeters)	Baseline and 30 minutes after two different interventions (different tensions). A one-week washout period was implemented between applications

Collaborators and Investigators

• Sponsor: Haydarpasa Numune Training and Research Hospital
• Investigators: Study Chair: Elem Yorulmaz, Prof, Haydarpaşa Numune Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2024
• Primary Completion (Actual): August 30, 2024
• Study Completion (Actual): August 30, 2024

Study Registration Dates

• First Submitted: July 9, 2026
• First Submitted That Met QC Criteria: July 9, 2026
• First Posted (Actual): July 15, 2026

Study Record Updates

• Last Update Posted (Actual): July 15, 2026
• Last Update Submitted That Met QC Criteria: July 9, 2026
• Last Verified: July 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: HNEAH-KAEK 2024/44

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No